This brand name is authorized in Singapore
The drug TRIPACEL contains a combination of these active pharmaceutical ingredients (APIs):
1
Diphtheria toxoid
UNII 3U7E3O07S8 - CORYNEBACTERIUM DIPHTHERIAE
|
|
2
Tetanus toxoid
UNII K3W1N8YP13 - CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
3 Pertussis toxoid |
|
4
Pertussis filamentous hemagglutinin
UNII 8C367IY4EY - BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)
|
|
5
Pertactin
UNII 2QNL82089R - BORDETELLA PERTUSSIS
|
|
6
Fimbriae (agglutinogens 2+3)
UNII 63GD90PP8X - BORDETELLA PERTUSSIS PERTACTIN ANTIGEN
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
J07AJ52 | Pertussis, purified antigen, combinations with toxoids | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AJ Pertussis vaccines |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: SG | Health Sciences Authority | Identifier(s): 10826P |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.